ASBP (Aspire Biopharma Holdings, Inc. Common Stock) Stock Analysis - SEC Filings

Aspire Biopharma Holdings, Inc. Common Stock (ASBP) is a publicly traded Healthcare sector company. As of May 21, 2026, ASBP trades at $5.95 with a market cap of $8.09M and a P/E ratio of 0.00. ASBP moved +2.06% today. Year to date, ASBP is -95.82%; over the trailing twelve months it is -97.91%. Its 52-week range spans $3.31 to $11,832.00. Rallies surfaces ASBP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find ASBP SEC filings?

Rallies organizes ASBP SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

ASBP Key Metrics

Key financial metrics for ASBP
MetricValue
Price$5.95
Market Cap$8.09M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.16%
52-Week High$11,832.00
52-Week Low$3.31
Volume1.94K
Avg Volume0
Revenue (TTM)$6.20K
Net Income$-24.48M
Gross Margin0.00%

Latest ASBP News

Recent ASBP Insider Trades

  • Fell Donald G. bought 10.50K (~$4.09K) on Jun 5, 2025.
  • Fell Donald G. sold 10.50K (~$4.09K) on Jun 5, 2025.
  • Fell Donald G. bought 9.50K (~$3.71K) on Jun 4, 2025.

ASBP Analyst Consensus

ASBP analyst coverage data. Average price target: $0.00.

Common questions about ASBP

Where can I find ASBP SEC filings?
Rallies organizes ASBP SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show ASBP 10-K and 10-Q filings?
Rallies organizes ASBP SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is ASBP research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ASBP. It does not provide personalized investment advice.
ASBP

ASBP